We got a mention... "Other notable therapies
Post# of 154563
(Total Views: 653)
Posted On: 05/09/2025 4:28:11 PM
We got a mention...
"Other notable therapies in late-stage development include CytoDyn’s once-weekly leronlimab, which is expected to be used in patients with CCR5-type virus, and Gilead’s biannual injectable lenacapavir for pre-exposure prophylaxis (PrEP)**."
https://www.globaldata.com/media/pharma/hiv-m...lobaldata/
(9)
(0)